期刊论文详细信息
ClinicoEconomics and Outcomes Research
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
关键词: baricitinib;    cost-effectiveness;    JAK inhibitor;    rheumatoid arthritis;   
DOI  :  
来源: DOAJ
【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次